{"id":"https://openalex.org/W1963566334","doi":"https://doi.org/10.1016/0277-5379(85)90018-5","title":"Inactivation of \u03c6X174 DNA by the ortho-quinone derivative or its reduction product of the antitumor agent VP 16-213","display_name":"Inactivation of \u03c6X174 DNA by the ortho-quinone derivative or its reduction product of the antitumor agent VP 16-213","publication_year":1985,"publication_date":"1985-10-01","ids":{"openalex":"https://openalex.org/W1963566334","doi":"https://doi.org/10.1016/0277-5379(85)90018-5","mag":"1963566334","pmid":"https://pubmed.ncbi.nlm.nih.gov/2934259"},"language":"en","primary_location":{"id":"doi:10.1016/0277-5379(85)90018-5","doi":"https://doi.org/10.1016/0277-5379(85)90018-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0277-5379(85)90018-5","pdf_url":null,"source":{"id":"https://openalex.org/S42075721","display_name":"European Journal of Cancer and Clinical Oncology","issn_l":"0277-5379","issn":["0277-5379","1878-5980"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer and Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pure.amsterdamumc.nl/en/publications/b9093658-2600-462b-97ad-20bda749054a","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108665048","display_name":"Jan M. S. van Maanen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.M.S. Van Maanen","raw_affiliation_strings":["Department of Oncology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113652377","display_name":"C. De Ruiter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C. De Ruiter","raw_affiliation_strings":["Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113678607","display_name":"Peter R. Kootstra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P.R. Kootstra","raw_affiliation_strings":["Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110072576","display_name":"M.V.M. Lafleur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M.V.M. Lafleur","raw_affiliation_strings":["Department of Biophysics, Physics Laboratory of the Free University, De Boelelaan 1081, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biophysics, Physics Laboratory of the Free University, De Boelelaan 1081, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111625774","display_name":"John de Vries","orcid":"https://orcid.org/0000-0002-4984-3936","observed_orcids":["https://orcid.org/0000-0002-4984-3936"]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. De Vries","raw_affiliation_strings":["Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Molecular Toxicology, Department of Pharmacochemistry, Free University, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055105229","display_name":"J. Ret\u00e8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. Ret\u00e8l","raw_affiliation_strings":["Department of Biophysics, Physics Laboratory of the Free University, De Boelelaan 1081, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biophysics, Physics Laboratory of the Free University, De Boelelaan 1081, 1081 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105878379","display_name":"Herbert M. Pinedo","orcid":"https://orcid.org/0000-0002-8980-371X","observed_orcids":["https://orcid.org/0000-0002-8980-371X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.M. Pinedo","raw_affiliation_strings":["Department of Oncology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.107,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.96294028,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"10","first_page":"1215","last_page":"1218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9279999732971191},{"id":"https://openalex.org/keywords/phi-x174-dna","display_name":"phi X174 DNA","score":0.8100000023841858},{"id":"https://openalex.org/keywords/dna-inactivation","display_name":"DNA inactivation","score":0.9049999713897705},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7210000157356262},{"id":"https://openalex.org/keywords/nadph-cytochrome-p450-reductase","display_name":"NADPH-cytochrome P450 reductase","score":0.9229999780654907},{"id":"https://openalex.org/keywords/nadph-reduction","display_name":"NADPH reduction","score":0.871999979019165},{"id":"https://openalex.org/keywords/phenoxyl-radicals","display_name":"phenoxyl radicals","score":0.9070000052452087},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.6819999814033508},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780643102","wikidata":"https://www.wikidata.org/wiki/Q412382","display_name":"Quinone","level":2,"score":0.9528908729553223},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7860115170478821},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.6590032577514648},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.5265552997589111},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5069301724433899},{"id":"https://openalex.org/C2780768313","wikidata":"https://www.wikidata.org/wiki/Q408068","display_name":"Cytochrome","level":3,"score":0.46667659282684326},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28186386823654175},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20594531297683716},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004277","descriptor_name":"DNA, Single-Stranded","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009249","descriptor_name":"NADP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010584","descriptor_name":"Bacteriophage phi X 174","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011034","descriptor_name":"Podophyllotoxin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/0277-5379(85)90018-5","doi":"https://doi.org/10.1016/0277-5379(85)90018-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0277-5379(85)90018-5","pdf_url":null,"source":{"id":"https://openalex.org/S42075721","display_name":"European Journal of Cancer and Clinical Oncology","issn_l":"0277-5379","issn":["0277-5379","1878-5980"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer and Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:2934259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2934259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer & clinical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/b9093658-2600-462b-97ad-20bda749054a","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/b9093658-2600-462b-97ad-20bda749054a","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van Maanen, J M S, de Ruiter, C, Kootstra, P R, Lafleur, M V M, de Vries, J, Ret\u00e9l, J & Pinedo, H M 1985, 'Inactivation of YXl74 DNA by the ortho-quinone derivative or its reduction product of the anti tumor agent VP 16 213', European journal of cancer & clinical oncology, vol. 21, no. 10, pp. 1215-1218.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu1:oai:dare.ubvu.vu.nl:1871/3930","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1871/3930","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"TITLE=None","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/5da03603-4eac-4d98-acdf-95e7cf66a4b0","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/5da03603-4eac-4d98-acdf-95e7cf66a4b0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Cancer and Clinical Oncology, 21(10), 1215 - 1218. Pergamon Press","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/b9093658-2600-462b-97ad-20bda749054a","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/b9093658-2600-462b-97ad-20bda749054a","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van Maanen, J M S, de Ruiter, C, Kootstra, P R, Lafleur, M V M, de Vries, J, Ret\u00e9l, J & Pinedo, H M 1985, 'Inactivation of YXl74 DNA by the ortho-quinone derivative or its reduction product of the anti tumor agent VP 16 213', European journal of cancer & clinical oncology, vol. 21, no. 10, pp. 1215-1218.","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1554159232","https://openalex.org/W1952290204","https://openalex.org/W1972803807","https://openalex.org/W1987382221","https://openalex.org/W1988617504","https://openalex.org/W2020618842","https://openalex.org/W2060651663","https://openalex.org/W2073983482","https://openalex.org/W2090577711","https://openalex.org/W2103681475","https://openalex.org/W4302035473"],"related_works":["https://openalex.org/W2052332489","https://openalex.org/W6982370386","https://openalex.org/W2026721580","https://openalex.org/W7009592824","https://openalex.org/W7024421660","https://openalex.org/W2028839904","https://openalex.org/W7056348874","https://openalex.org/W2240746254","https://openalex.org/W7100712556","https://openalex.org/W2093258581"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}